Generic drug industry outlook
A look at the future of generics via a video interview with Thomson Reuters Director of Generics, Kate Kuhrt.
April 2009
Unlike other parts of the pharmaceutical industry, the generics industry has been favored on Wall Street since President Obama unveiled his healthcare plan. In this interview, Kate Kuhrt, Director of Generics at Thomson Reuters provides insight on the generic drugs landscape, including hot topics identified at the DCAT meeting, joined by Reuters Healthcare Correspondent Lewis Krauskopf.
Generic drug industry outlook: watch the interview
Further information
Generic drug industry outlook: watch the interview
Was this article useful?
Register now to receive KnowledgeLink direct to your mailbox every two months.